U.S. judge bars Martin Shkreli from drug industry, orders $64.6 million payment

  • 📰 YahooNews
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 59%

United States News News

United States United States Latest News,United States United States Headlines

Martin Shkreli famously raised the price of Daraprim, a drug used to treat toxoplasmosis, a parasitic infection that threatens people with weakened immune systems.

WASHINGTON -A U.S. judge on Friday barred Martin Shkreli from the pharmaceutical industry for life and ordered him to pay $64.6 million after he famously raised the price of Daraprim and fought to block generic competitors.

Shkreli drew notoriety in 2015 after hiking Daraprim's price overnight to $750 per tablet from $17.50. The drug treats toxoplasmosis, a parasitic infection that threatens people with weakened immune systems. She said the Daraprim scheme was "particularly heartless and coercive," and a lifetime industry ban was needed because of the "real danger" that Shkreli could become a repeat offender.

Neither Shkreli's lawyers nor the FTC immediately responded to requests for comment. The nonjury trial was held last month.Vyera was founded in 2014 as Turing Pharmaceuticals, and acquired Daraprim from Impax Laboratories Inc in 2015.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

So we can bar a private citizen from a private industry for the damage he caused to it and the people his decisions negatively affected but we cant bar a private citizen from public office for attempting to overthrow the government

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 380. in US

United States United States Latest News, United States United States Headlines